vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Driven Brands Holdings Inc. (DRVN). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $535.7M, roughly 1.8× Driven Brands Holdings Inc.). Driven Brands Holdings Inc. runs the higher net margin — 11.4% vs 0.7%, a 10.7% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 6.6%). Driven Brands Holdings Inc. produced more free cash flow last quarter ($39.5M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -4.0%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Standard Brands was a packaged foods company, formed in 1929 by J. P. Morgan & Co. with the merger of:Fleischmann Company Royal Baking Powder Company E. W. Gillett Company of Canada (1929) - Toronto-based baking goods company founded by P. W. Gillett in 1852 Widlar Food Products Company Chase & Sanborn Coffee Company

ASTH vs DRVN — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.8× larger
ASTH
$950.5M
$535.7M
DRVN
Growing faster (revenue YoY)
ASTH
ASTH
+36.3% gap
ASTH
42.9%
6.6%
DRVN
Higher net margin
DRVN
DRVN
10.7% more per $
DRVN
11.4%
0.7%
ASTH
More free cash flow
DRVN
DRVN
$45.4M more FCF
DRVN
$39.5M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
-4.0%
DRVN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASTH
ASTH
DRVN
DRVN
Revenue
$950.5M
$535.7M
Net Profit
$6.6M
$60.9M
Gross Margin
Operating Margin
1.9%
11.6%
Net Margin
0.7%
11.4%
Revenue YoY
42.9%
6.6%
Net Profit YoY
184.4%
507.2%
EPS (diluted)
$0.12
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
DRVN
DRVN
Q4 25
$950.5M
Q3 25
$956.0M
$535.7M
Q2 25
$654.8M
$551.0M
Q1 25
$620.4M
$516.2M
Q4 24
$665.2M
$836.5M
Q3 24
$478.7M
$502.3M
Q2 24
$486.3M
$518.8M
Q1 24
$404.4M
$482.0M
Net Profit
ASTH
ASTH
DRVN
DRVN
Q4 25
$6.6M
Q3 25
$373.0K
$60.9M
Q2 25
$9.4M
$47.6M
Q1 25
$6.7M
$5.5M
Q4 24
$-7.8M
$-312.0M
Q3 24
$16.1M
$-14.9M
Q2 24
$19.2M
$30.2M
Q1 24
$14.8M
$4.3M
Operating Margin
ASTH
ASTH
DRVN
DRVN
Q4 25
1.9%
Q3 25
2.0%
11.6%
Q2 25
3.1%
6.9%
Q1 25
3.3%
11.9%
Q4 24
0.1%
-41.6%
Q3 24
5.9%
9.9%
Q2 24
6.2%
17.4%
Q1 24
7.5%
14.1%
Net Margin
ASTH
ASTH
DRVN
DRVN
Q4 25
0.7%
Q3 25
0.0%
11.4%
Q2 25
1.4%
8.6%
Q1 25
1.1%
1.1%
Q4 24
-1.2%
-37.3%
Q3 24
3.4%
-3.0%
Q2 24
3.9%
5.8%
Q1 24
3.7%
0.9%
EPS (diluted)
ASTH
ASTH
DRVN
DRVN
Q4 25
$0.12
Q3 25
$0.01
$0.37
Q2 25
$0.19
$0.29
Q1 25
$0.14
$0.04
Q4 24
$-0.14
$-1.93
Q3 24
$0.33
$-0.09
Q2 24
$0.40
$0.18
Q1 24
$0.31
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
DRVN
DRVN
Cash + ST InvestmentsLiquidity on hand
$429.5M
$162.0M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$779.3M
$793.5M
Total Assets
$2.2B
$4.2B
Debt / EquityLower = less leverage
2.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
DRVN
DRVN
Q4 25
$429.5M
Q3 25
$463.4M
$162.0M
Q2 25
$342.1M
$166.1M
Q1 25
$260.9M
$152.0M
Q4 24
$290.8M
$149.6M
Q3 24
$350.3M
$204.2M
Q2 24
$327.7M
$148.8M
Q1 24
$337.3M
$165.5M
Total Debt
ASTH
ASTH
DRVN
DRVN
Q4 25
Q3 25
$1.9B
Q2 25
$2.1B
Q1 25
$2.6B
Q4 24
$2.7B
Q3 24
$2.7B
Q2 24
$2.9B
Q1 24
$2.9B
Stockholders' Equity
ASTH
ASTH
DRVN
DRVN
Q4 25
$779.3M
Q3 25
$775.5M
$793.5M
Q2 25
$765.5M
$743.4M
Q1 25
$745.4M
$643.2M
Q4 24
$712.7M
$607.3M
Q3 24
$704.6M
$962.8M
Q2 24
$678.9M
$942.8M
Q1 24
$653.5M
$906.2M
Total Assets
ASTH
ASTH
DRVN
DRVN
Q4 25
$2.2B
Q3 25
$2.2B
$4.2B
Q2 25
$1.4B
$4.3B
Q1 25
$1.3B
$5.3B
Q4 24
$1.4B
$5.3B
Q3 24
$1.3B
$5.8B
Q2 24
$1.3B
$5.8B
Q1 24
$1.2B
$5.9B
Debt / Equity
ASTH
ASTH
DRVN
DRVN
Q4 25
Q3 25
2.44×
Q2 25
2.82×
Q1 25
4.07×
Q4 24
4.37×
Q3 24
2.84×
Q2 24
3.03×
Q1 24
3.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
DRVN
DRVN
Operating Cash FlowLast quarter
$-2.9M
$79.2M
Free Cash FlowOCF − Capex
$-6.0M
$39.5M
FCF MarginFCF / Revenue
-0.6%
7.4%
Capex IntensityCapex / Revenue
0.3%
7.4%
Cash ConversionOCF / Net Profit
-0.44×
1.30×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$31.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
DRVN
DRVN
Q4 25
$-2.9M
Q3 25
$10.0M
$79.2M
Q2 25
$90.9M
$80.4M
Q1 25
$16.6M
$75.1M
Q4 24
$-10.9M
$32.9M
Q3 24
$34.0M
$101.3M
Q2 24
$23.2M
$46.9M
Q1 24
$6.0M
$60.3M
Free Cash Flow
ASTH
ASTH
DRVN
DRVN
Q4 25
$-6.0M
Q3 25
$7.4M
$39.5M
Q2 25
$89.5M
$9.0M
Q1 25
$13.6M
$18.9M
Q4 24
$-13.5M
$-36.3M
Q3 24
$31.7M
$37.9M
Q2 24
$20.4M
$-19.5M
Q1 24
$5.6M
$-29.2M
FCF Margin
ASTH
ASTH
DRVN
DRVN
Q4 25
-0.6%
Q3 25
0.8%
7.4%
Q2 25
13.7%
1.6%
Q1 25
2.2%
3.7%
Q4 24
-2.0%
-4.3%
Q3 24
6.6%
7.5%
Q2 24
4.2%
-3.8%
Q1 24
1.4%
-6.1%
Capex Intensity
ASTH
ASTH
DRVN
DRVN
Q4 25
0.3%
Q3 25
0.3%
7.4%
Q2 25
0.2%
13.0%
Q1 25
0.5%
10.9%
Q4 24
0.4%
8.3%
Q3 24
0.5%
12.6%
Q2 24
0.6%
12.8%
Q1 24
0.1%
18.6%
Cash Conversion
ASTH
ASTH
DRVN
DRVN
Q4 25
-0.44×
Q3 25
26.69×
1.30×
Q2 25
9.65×
1.69×
Q1 25
2.48×
13.65×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
1.56×
Q1 24
0.40×
14.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

DRVN
DRVN

Company Operated Store Sales$331.3M62%
Supply And Other$74.3M14%
Car Wash Segment$54.0M10%
Independently Operated Store Sales$51.4M10%
Advertising$27.9M5%
Employee Services Leasing Agreement$2.0M0%

Related Comparisons